Positioning Nightmares
Let’s agree. Positioning should be active, not passive.
Mike Rea
December 14, 2016 - Let’s agree. Positioning should be active, not passive.
Read More
Biosimilar
Will the period we are entering now see the biosimilars market come of age?
James Bohan
November 18, 2016 - Will the period we are entering now see the biosimilars market come of age?
Read More
When does a new drug become too expensive? When it's combined with another one...
New treatments test the limits of premium pricing
James Bohan
October 12, 2016 - New treatments test the limits of premium pricing
Read More
What is innovation?
Innovation is what you launch
Mike Rea
October 11, 2016 - Innovation is what you launch
Read More
Why innovate when you can buy someone else's innovation?
The direction Pharma is heading
James Bohan
October 07, 2016 - The direction Pharma is heading
Read More
The pace of innovation
How time has passed us by
John Tonra
October 07, 2016 - How time has passed us by
Read More
Fortune favours the brave, but chance only favours the smart
Bringing invention and inventors back into the heart of the R&D process
David Baines-Pinchen
September 30, 2016 - Bringing invention and inventors back into the heart of the R&D process
Read More
Product design in Pharma is unlike product design in most other industries
The immense unknown underlying most biological processes
Ralph Torbay
September 26, 2016 - The immense unknown underlying most biological processes
Read More